E
Elizabeth Sizer
Researcher at University of Cambridge
Publications - 34
Citations - 1404
Elizabeth Sizer is an academic researcher from University of Cambridge. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 14, co-authored 33 publications receiving 1288 citations. Previous affiliations of Elizabeth Sizer include King's College London & King's College.
Papers
More filters
Journal ArticleDOI
Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure
William Bernal,Catherine Hall,Constantine J. Karvellas,Georg Auzinger,Elizabeth Sizer,Julia Wendon +5 more
TL;DR: Ammonia is an independent risk factor for the development of both HE and ICH, and its combination with ammonia increased specificity and accuracy and improved the prediction of HE.
Journal ArticleDOI
Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experience
William Bernal,Timothy J.S. Cross,Georg Auzinger,Elizabeth Sizer,Michael A. Heneghan,Matthew Bowles,Paulo Muiesan,Mohammed Rela,Nigel Heaton,Julia Wendon,John O'Grady +10 more
TL;DR: Improved outcomes in the later era, despite higher level patient dependency and greater use of high-risk grafts, through improved graft/recipient matching is indicated.
Journal ArticleDOI
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension
Mark J Austin,N. I. McDougall,Julia Wendon,Elizabeth Sizer,A. S. Knisely,Mohammed Rela,Carol M. Wilson,M.E. Callender,John O'Grady,Michael A. Heneghan +9 more
TL;DR: This is the first reported patient with severe PPHTN using this combination of vasodilator therapy as a bridge to LT and then as maintenance in the posttransplantation phase, and this regimen may enable LT in similar patients in the future, without long‐term consequences.
Journal ArticleDOI
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
Matthew R. Foxton,M Al-Freah,Andrew J. Portal,Elizabeth Sizer,William Bernal,Georg Auzinger,Mohamed Rela,Julia Wendon,Nigel Heaton,John O'Grady,Michael A. Heneghan +10 more
TL;DR: Use of MELD as a method of organ allocation results in significant increase in ICU cost after LT, and TISS as surrogate marker for ICU costs reveals that the cost implications are related to the need for RRT and prolonged ICU stay.
Journal ArticleDOI
Intensive care management of acute liver failure.
TL;DR: Practical clinical approaches to the care of critically ill patients with ALF are discussed, taking an organ systems-based perspective and discussing the underlying pathophysiological processes and major areas of uncertainty as to what constitutes best practice.